Europe Endovascular Aneurysm Repair Market Size, Share & Industry Trends Analysis Report By Indication (Abdominal and Thoratic), By Product, By Site, By Anatomy (Traditional and Complex), By Country and Growth Forecast, 2022 - 2028

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Endovascular Aneurysm Repair Market, by Indication
1.4.2 Europe Endovascular Aneurysm Repair Market, by Product
1.4.3 Europe Endovascular Aneurysm Repair Market, by Site
1.4.4 Europe Endovascular Aneurysm Repair Market, by Anatomy
1.4.5 Europe Endovascular Aneurysm Repair Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Endovascular Aneurysm Repair Market
Chapter 4. Europe Endovascular Aneurysm Repair Market by Indication
4.1 Europe Abdominal Market by Country
4.2 Europe Thoratic Market by Country

Chapter 5. Europe Endovascular Aneurysm Repair Market by Product
5.1 Europe Percutaneous Evar Market by Country
5.2 Europe Fenestrated Evar Market by Country
5.3 Europe Aortic Stents & Taa Graft Market by Country
5.4 Europe Others Market by Country

Chapter 6. Europe Endovascular Aneurysm Repair Market by Site
6.1 Europe Infrarenal Market by Country
6.2 Europe Pararenal Market by Country

Chapter 7. Europe Endovascular Aneurysm Repair Market by Anatomy
7.1 Europe Traditional Market by Country
7.2 Europe Complex Market by Country

Chapter 8. Europe Endovascular Aneurysm Repair Market by Country
8.1 Germany Endovascular Aneurysm Repair Market
8.1.1 Germany Endovascular Aneurysm Repair Market by Indication
8.1.2 Germany Endovascular Aneurysm Repair Market by Product
8.1.3 Germany Endovascular Aneurysm Repair Market by Site
8.1.4 Germany Endovascular Aneurysm Repair Market by Anatomy
8.2 UK Endovascular Aneurysm Repair Market
8.2.1 UK Endovascular Aneurysm Repair Market by Indication
8.2.2 UK Endovascular Aneurysm Repair Market by Product
8.2.3 UK Endovascular Aneurysm Repair Market by Site
8.2.4 UK Endovascular Aneurysm Repair Market by Anatomy
8.3 France Endovascular Aneurysm Repair Market
8.3.1 France Endovascular Aneurysm Repair Market by Indication
8.3.2 France Endovascular Aneurysm Repair Market by Product
8.3.3 France Endovascular Aneurysm Repair Market by Site
8.3.4 France Endovascular Aneurysm Repair Market by Anatomy
8.4 Russia Endovascular Aneurysm Repair Market
8.4.1 Russia Endovascular Aneurysm Repair Market by Indication
8.4.2 Russia Endovascular Aneurysm Repair Market by Product
8.4.3 Russia Endovascular Aneurysm Repair Market by Site
8.4.4 Russia Endovascular Aneurysm Repair Market by Anatomy
8.5 Spain Endovascular Aneurysm Repair Market
8.5.1 Spain Endovascular Aneurysm Repair Market by Indication
8.5.2 Spain Endovascular Aneurysm Repair Market by Product
8.5.3 Spain Endovascular Aneurysm Repair Market by Site
8.5.4 Spain Endovascular Aneurysm Repair Market by Anatomy
8.6 Italy Endovascular Aneurysm Repair Market
8.6.1 Italy Endovascular Aneurysm Repair Market by Indication
8.6.2 Italy Endovascular Aneurysm Repair Market by Product
8.6.3 Italy Endovascular Aneurysm Repair Market by Site
8.6.4 Italy Endovascular Aneurysm Repair Market by Anatomy
8.7 Rest of Europe Endovascular Aneurysm Repair Market
8.7.1 Rest of Europe Endovascular Aneurysm Repair Market by Indication
8.7.2 Rest of Europe Endovascular Aneurysm Repair Market by Product
8.7.3 Rest of Europe Endovascular Aneurysm Repair Market by Site
8.7.4 Rest of Europe Endovascular Aneurysm Repair Market by Anatomy

Chapter 9. Company Profiles
9.1 Endologix LLC
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Product Launches and Product Expansions:
9.1.2.2 Approvals and Trials:
9.2 Lombard Medical Limited
9.2.1 Company Overview
9.3 Cardinal Health, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Recent strategies and developments:
9.3.4.1 Approvals and Trials:
9.4 Becton, Dickinson and Company
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Medtronic PLC
9.5.1 Company overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Approvals and Trials:
9.6 Cook Medical, Inc. (Cook Group)
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Partnerships, Collaborations, and Agreements:
9.6.2.2 Approvals and Trials:
9.7 Koninklijke Philips N.V.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Acquisition and Mergers:
9.8 Terumo Corporation
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Product Launches and Product Expansions:
9.8.4.2 Acquisition and Mergers:
9.9 Abbott Laboratories
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Acquisition and Mergers:
9.10. Artivion, Inc. (JOTEC GmbH)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense